PIEZO1 and diabetic kidney disease: Given their mechanosensory properties and DKD pathology, Piezo1 likely acts as a critical mediator linking mechanical stress (e.g., glomerular hypertension, hemodynamic shear forces) and metabolic disturbances to downstream inflammatory, oxidative, and fibrotic pathways.